JB/CALL/PFIZER INC/28/0.1/21.03.25 Stock

Warrant

PFYRJB

CH1308924823

Market Closed - Swiss Exchange 11:20:00 2024-05-31 am EDT
0.3 CHF +15.38% Intraday chart for JB/CALL/PFIZER INC/28/0.1/21.03.25
Current month+76.47%
1 month+76.47%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 0.3 +15.38%
24-05-29 0.26 -10.34%
24-05-28 0.29 -9.38%
24-05-23 0.32 -5.88%
24-05-22 0.34 +17.24%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 11:20 am EDT

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer Bank Julius Bär
PFYRJB
ISINCH1308924823
Date issued 2023-12-14
Strike 28 $
Maturity 2025-03-21 (294 Days)
Parity 10 : 1
Emission price 0.27 CHF
Emission volume N/A
Settlement Por diferencias
Currency CHF

Technical Indicators

Highest since issue 0.41 CHF
Lowest since issue 0.17 CHF
Delta0.57x
Omega 4.783
Premium10.02x
Gearing8.45x
Moneyness 1.019
Difference Strike -0.66 $
Difference Strike %-2.36%
Spread 0.01 CHF
Spread %3.23%
Theoretical value 0.3050
Implied Volatility 31.80 %
Total Loss Probability 52.99 %
Intrinsic value 0.0470
Present value 0.2580
Break even 31.38 CHF
Theta-0x
Vega0.01x
Rho0.01x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
28.66 USD
Average target price
31.92 USD
Spread / Average Target
+11.36%
Consensus
  1. Stock Market
  2. Warrants
  3. PFYRJB Warrant